Group One Trading
GHDX

Group One Trading’s Genomic Health, Inc. GHDX Stock Holding History

Group One Trading’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,500
Closed -$102K – 5963
2019
Q3 		$102K Buy
+1,500
New +$103K ﹤0.01% 3544
2019
Q2 		– Sell
-3,900
Closed -$273K – 5691
2019
Q1 		$273K Buy
+3,900
New +$289K ﹤0.01% 2463
2015
Q3 		– Sell
-1,200
Closed -$33K – 5405
2015
Q2 		$33K Sell
1,200
-30,000
-96% -$846K ﹤0.01% 3790
2015
Q1 		$953K Buy
31,200
+26,500
+564% +$842K 0.02% 1121
2014
Q4 		$150K Sell
4,700
-1,000
-18% -$32.5K ﹤0.01% 2537
2014
Q3 		$161K Buy
5,700
+3,500
+159% +$97.6K ﹤0.01% 2557
2014
Q2 		$60K Sell
2,200
-5,400
-71% -$144K ﹤0.01% 3411
2014
Q1 		$200K Buy
7,600
+7,400
+3,700% +$212K ﹤0.01% 2449
2013
Q4 		$6K Sell
200
-2,500
-93% -$79.3K ﹤0.01% 4813
2013
Q3 		$83K Sell
2,700
-6,900
-72% -$231K ﹤0.01% 3178
2013
Q2 		$304K Buy
+9,600
New +$315K 0.01% 1785

Group One Trading's GHDX Position: Q3 2019 in Review

Group One Trading sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 2,131 shares — an estimated $146K sold.

Group One Trading first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $385K in Q1 2015. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Group One Trading reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Group One Trading sold 2,131 Genomic Health, Inc. shares in Q3 2019, an estimated $146K.
  • Group One Trading first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Genomic Health, Inc. position peaked at $385K in Q1 2015.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.